Back to Search Start Over

Time course of polyglutamine aggregate body formation and cell death: Enhanced growth in nucleus and an interval for cell death

Authors :
K. Kato
Shoji Tsuji
Osamu Onodera
Itaru Toyoshima
Takayoshi Shimohata
Reiji Koide
Masashiro Sugawara
C. Wada
Source :
Journal of Neuroscience Research. 68:442-448
Publication Year :
2002
Publisher :
Wiley, 2002.

Abstract

Polyglutamine (polyQ) aggregate bodies are a hallmark of dentatorubral-pallidoluysian atrophy and related neurodegenerative disorders, although the relationship between aggregate body formation and cell death is not clear. We analyzed the kinetics of polyQ aggregate formation and the time intervals for cell death, tracking individual cells using fluorescence video microscopy, for the first time. Expanded polyQ tracts of atrophin-1 with or without nuclear localization signal (NLS) labeled with green fluorescent protein (GFP) were constructed, Q57NLS/GFP and Q56/GFP, respectively. All of the Q57NLS/GFP aggregate bodies were in nuclei, and all of the Q56/GFP aggregate bodies were in cytoplasm. Aggregates of Q56/GFP were larger than those of Q57NLS/GFP. Surprisingly, a kinetic analysis showed that the latter grew 5.37 times faster than the former. The time interval between transfection and cell death was shorter in Q57NLS/GFP, but the time between the end of the rapid growing phase of aggregation and the start of the cell death process did not show a significant difference. Aggregate growth was confirmed to correspond to the accumulated free polyQ by the time of starting aggregation. These findings suggest that aggregate body formation induced by expanded polyQ stretches is a self-limiting process and is enhanced by factor(s) in nuclei, whereas it is not tightly bound to the cell death process. © 2002 Wiley-Liss, Inc.

Details

ISSN :
10974547 and 03604012
Volume :
68
Database :
OpenAIRE
Journal :
Journal of Neuroscience Research
Accession number :
edsair.doi.dedup.....a18433410623ecd778c94744b982a9f0
Full Text :
https://doi.org/10.1002/jnr.10233